- Home
- MIRM vs ORLA Comparison
MIRM vs ORLA Comparison
Compare MIRM & ORLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIRM
- ORLA
- Stock Information
- Founded
- MIRM 2018
- ORLA 2007
- Country
- MIRM United States
- ORLA Canada
- Employees
- MIRM N/A
- ORLA N/A
- Industry
- MIRM Biotechnology: Pharmaceutical Preparations
- ORLA Precious Metals
- Sector
- MIRM Health Care
- ORLA Basic Materials
- Exchange
- MIRM Nasdaq
- ORLA Nasdaq
- Market Cap
- MIRM 3.7B
- ORLA 3.1B
- IPO Year
- MIRM 2019
- ORLA N/A
- Fundamental
- Price
- MIRM $70.45
- ORLA $11.81
- Analyst Decision
- MIRM Strong Buy
- ORLA Buy
- Analyst Count
- MIRM 11
- ORLA 1
- Target Price
- MIRM $82.82
- ORLA $27.00
- AVG Volume (30 Days)
- MIRM 596.2K
- ORLA 1.9M
- Earning Date
- MIRM 11-04-2025
- ORLA 11-11-2025
- Dividend Yield
- MIRM N/A
- ORLA N/A
- EPS Growth
- MIRM N/A
- ORLA 2239.45
- EPS
- MIRM N/A
- ORLA 0.16
- Revenue
- MIRM $471,794,000.00
- ORLA $772,153,000.00
- Revenue This Year
- MIRM $53.14
- ORLA $182.00
- Revenue Next Year
- MIRM $19.83
- ORLA $38.17
- P/E Ratio
- MIRM N/A
- ORLA $74.33
- Revenue Growth
- MIRM 53.66
- ORLA 145.83
- 52 Week Low
- MIRM $36.88
- ORLA $4.29
- 52 Week High
- MIRM $78.55
- ORLA $13.91
- Technical
- Relative Strength Index (RSI)
- MIRM 50.06
- ORLA 54.92
- Support Level
- MIRM $68.60
- ORLA $11.27
- Resistance Level
- MIRM $73.02
- ORLA $13.18
- Average True Range (ATR)
- MIRM 3.10
- ORLA 0.66
- MACD
- MIRM 0.08
- ORLA 0.17
- Stochastic Oscillator
- MIRM 54.27
- ORLA 62.73
About MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.
About ORLA Orla Mining Ltd.
Orla Mining Ltd is a mineral exploration company. It is engaged in the acquisition and exploration of mineral properties. The company holds three gold projects; the Camino Rojo gold and silver project in Zacatecas State, Musselwhite gold mine project located in Ontario and the South Railroad projects in Nevada, USA, and the Cerro Quema gold project in Panama. It conducts business activities in Mexico, Panama, the United States, and Canada.